Jianguo Shi
Xian, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications
A hybrid system integrating xylose dehydrogenase and NAD+ coupled with PtNPs@MWCNTs composite for the real-time biosensing of xylose.
Journal: The Analyst
Published: July 03, 2020
Randomized, double-blind, 6-week non-inferiority study of lurasidone and risperidone for the treatment of schizophrenia.
Journal: Psychiatry and clinical neurosciences
Published: July 01, 2019
What is the optimal neuropsychological test battery for schizophrenia in China?
Journal: Schizophrenia research
Published: July 16, 2018
Safety and efficacy of paliperidone palmitate 1-month formulation in Chinese patients with schizophrenia: a 25-week, open-label, multicenter, Phase IV study.
Journal: Neuropsychiatric disease and treatment
Published: August 18, 2017
A 6-week, multicenter, double-blind, double-dummy, chlorpromazine-controlled non-inferiorityrandomized phase iiitrial to evaluate the efficacy and safety of quetiapine fumarate (SEROQUEL) extended-release (XR) in the treatment of patients with schizophrenia and acute episodes.
Journal: Psychiatry research
Published: September 01, 2016
Safety and efficacy of paliperidone extended-release in Chinese patients with schizophrenia: a 24-week, open-label extension of a randomized, double-blind, placebo-controlled study.
Journal: Neuropsychiatric disease and treatment
Published: January 27, 2016
The MATRICS Consensus Cognitive Battery (MCCB): Co-norming and standardization in China.
Journal: Schizophrenia research
Published: June 13, 2015
Efficacy and safety of quetiapine extended release monotherapy in bipolar depression: a multi-center, randomized, double-blind, placebo-controlled trial.
Journal: Psychopharmacology
Published: June 07, 2015
Comparative study of the efficacy and safety between blonanserin and risperidone for the treatment of schizophrenia in Chinese patients: A double-blind, parallel-group multicenter randomized trial.
Journal: Journal of psychiatric research
Published: March 27, 2015
Recognition and identification of active components from Radix Bupleuri using human neuroblastoma SH-SY5Y cells.
Journal: Biomedical chromatography : BMC
Published: January 16, 2015
Response to Baguley et al. concerning the use of the quantum resonance spectrometer to detect psychiatric symptoms.
Journal: The Journal of nervous and mental disease
Published: December 24, 2014
Last Updated: 09/26/2026